Tag Archives: Sentra PM

Research Identifies a Potential New Path to Developing a Treatment for Chronic Pain

Los Angeles, September 8, 2015 – Targeted Medical Pharma to present new chronic pain research that reveals significant nervous system abnormalities among patients suffering from Fibromyalgia, at the 2015 PainWeek national conference in Las Vegas, Nevada. The study looked at 329 Fibromyalgia patients and 58 control patients all of whom wore Holter monitors for a 24 hour period to measure nervous system activity. The results of this study showed that patients with Fibromyalgia experience a significant decrease in both nighttime parasympathetic nervous system (PNS) activity and daytime sympathetic Continue reading →

Targeted Medical Pharma Releases Promising Trial Results for the Treatment of Posttraumatic Stress Disorder

Study Shows Medical Foods Sentra AM and Sentra PM Effective at Reducing Symptoms of PTSD in Veterans Los Angeles, CA, October  13, 2014 — Targeted Medical Pharma, Inc. (OTCQB: TRGM) a drug discovery and development company, today announced the results of a clinical trial studying the amino acid based medical foods, Sentra AM and Sentra PM in Veterans suffering from symptoms associated with Posttraumatic Stress Disorder (PTSD). In this 30 day open label pilot study (n=21), published in the Journal of Central Nervous System Disease, Continue reading →

Targeted Medical Pharma Appoints Two New Independent Members to the Board of Directors

 Health Care Veteran Kerry Weems and Corporate Finance Expert Paul Pelosi, Jr. Join the Advisory Team Los Angeles, CA, June 13, 2014 — Targeted Medical Pharma, Inc. (OTCQB: TRGM), today announced the addition of two independent members to the Company’s board of directors. The Company welcomes back health care specialist Kerry Weems to the board as an independent director and chairman of the Nominating and Governance Committee, as well as corporate finance expert Paul Pelosi, Jr. as an independent director. A nationally respected expert in Continue reading →

Targeted Medical Pharma Looks to China as the Next Medical Food Market

Company discusses distribution of medical foods with large Chinese pharmaceutical company  Los Angeles, May 20, 2014 – Targeted Medical Pharma (OTCQB: TRGM), is currently discussing the logistics of importing the Company’s medical food products into China, with a large Chinese pharmaceutical company. No assurances can be made that a definitive agreement will be consummated between the two Companies at this time. “Growth of international sales and distribution will contribute to the success of our 2014 fiscal initiatives,” said William Shell, M.D. Chief Executive Officer and Continue reading →

Targeted Medical Pharma Announces Completion of Sales Agreement with Pacific Medical, Inc

Agreement Provides the Company with the Ability to Rapidly Expand Sales and Education Programs Los Angeles, CA, January 10, 2014 — Targeted Medical Pharma, Inc. (OTCQB: TRGM), reported on the completion of an independent sales agreement with Pacific Medical, Inc., a distributor of durable medical equipment in the United States who specializes in orthopedic, rehabilitation, surgery and sports medicine. The non-exclusive agreement will allow Targeted Medical Pharma to expand medical food sales and education programs to licensed healthcare professionals in Northern California and Northern Nevada Continue reading →

Targeted Medical Pharma to Present at the Demy-Colton 2014 BIOTECH Showcase

Targeted Medical Pharma to Present at the Demy-Colton 2014 BIOTECH Showcase Los Angeles, January 9, 2014 — Targeted Medical Pharma, announced that members of its executive team are scheduled to present the latest information regarding medical foods at the sixth annual Biotech Showcase™ on January 14, 2014 at 4:00 p.m. PST, at the Parc 55 Wyndham Hotel in San Francisco, CA. Management also will conduct one-on-one meetings with investors from January 13-15, 2014. Biotech Showcase is an investor and partnering conference devoted to providing private Continue reading →

Targeted Medical Pharma Reports Initial Results from a Clinical Observation of Medical Foods for Children and Adults with Autistic Spectrum Disorder Symptoms

Addressing the Nutrient Deficiencies Associated with Autism Spectrum Disorders for both Children and Adults Los Angeles, CA, December 23, 2013 — Targeted Medical Pharma, Inc. (OTCQB: TRGM), announced additional preliminary findings from an investigator initiated clinical observation of amino acid based medical foods to address specific nutrient deficiencies in children and young adults with autism spectrum disease (ASD) symptoms. 34 subjects including 29 children and 5 young adults ages seven to twenty-one who were diagnosed with ASD or suffering from related symptoms including explosive behavior, Continue reading →

Targeted Medical Pharma Reports 2013 Second Quarter Financial Results

— Year-Over-Year Revenue Increase of 67% and Gross Profit  Increase of 97% for the first half of 2013– LOS ANGELES—August 14, 2013–Targeted Medical Pharma, Inc. (OTCQB:TRGM), a biotechnology company that develops and distributes prescription medical foods, convenience kits and generic pharmaceuticals to physicians and pharmacies, today announced financial results for its second quarter ended June 30, 2013. The Company continued to post increasing revenue for the second quarter and first half of 2013 compared to the second quarter and first half of 2012. “I am Continue reading →

California Physicians Find Medical Foods Clinically Beneficial

Clinically Supported, FDA-Regulated Medications Managing Chronic Disease without Costly Side-Effects Los Angeles, August 5th, 2013 — Prescription-only medical foods are a growing therapeutic alternative to many commonly prescribed pharmaceuticals among California physicians, according to Targeted Medical Pharma, Inc.(OTCQB:TRGM), a biotechnology company that develops these prescription medications for chronic diseases, including pain syndromes, peripheral neuropathy, hypertension, obesity, sleep and cognitive disorders. “Medical foods are shown to be safe and effective,” said Lonna Larsh, M.D., a Santa Cruz-based family physician, who recently started prescribing medical foods to Continue reading →

Survey Shows Most Americans do not Get a Good Night’s Sleep

Anxiety, Mind Racing and Pain are Largest Culprits for the Sleep Deprived; Only 25 Percent Would Be Willing to Use Prescription Sleep Aid LOS ANGELES, June 3, 2013 — Eighty three percent of Americans say they do not always get a good night’s sleep on a regular basis, according to the 2013 Rx Sleep Survey conducted by Harris Interactive on behalf of Targeted Medical Pharma, Inc. (OTCQB: TRGM), a Los Angeles-based biotechnology company.  The results also revealed that while only 25 percent of Americans would Continue reading →